To support strong collaboration between Federal research agencies, NIH has made every effort to align the Biographical Sketch (Biosketch), Other Support format page, and Application Form Instructions with the guidance issued by the Office of Science and Technology Policy Joint Committee on the Research Environment. As a result, NIH has released a notice (NOT-OD-21-073) that outlines updates to application forms and instructions to support applicants and recipients' need to provide full transparency and disclosure of all research activities, foreign and domestic. The updated form and instructions will be required for use for applications and Research Performance Progress Reports (RPPRs) submitted for due dates on or after May 25, 2021.

We want to alert you that the changes to the Other Support requirements are significant and much more than simply a change in format. You should review the new template and take some time to read NIH’s FAQ page about the Other Support requirements.

Above all, you should work with your department administrator to update your Other Support documentation now, so that you have it readily available if it is requested by the Cancer Center research administration team for an upcoming progress report or grant proposal. If you have any questions about the new Other Support page and your own department administrator cannot assist, we are happy to help you update or create yours before you’re hit with a deadline! Please reach out to casecccfinance@case.edu and let us know if you have questions or need assistance.

Avoid errors and warnings during submissions by joining the SOM Office of Research Administration on Wednesday, April 21 from 12-1:30 pm for a workshop to help faculty navigate and understand NIH policies for submitting grant proposals! The recently released NIH guidelines for Biosketches and Other Support pages will also be discussed in detail. The 90-minute virtual session will be led by Erin Fogarty, Assistant Dean for Research Administration, and staff from the SOM Office of Grants and Contracts. Registration details will be available soon - email Maita Diaz with questions.

We are pleased to announce four new appointments to our External Advisory Committee. We look forward to introducing them to our center and will look to them for guidance as we begin to prepare for our center grant renewal.

Anita Y. Kinney, PhD is associate director for cancer health equity and engagement at Rutgers Cancer Institute of New Jersey and director of ScreenNJ, a statewide cancer prevention and screening program. She is also a professor in the Department of Biostatistics and Epidemiology and director of the Center for Cancer Health Equity at the School of Public Health at Rutgers University.

Adekunle "Kunle" Odunsi, MD, PhD was appointed director of the University of Chicago Medicine Comprehensive Cancer Center effective March 1, 2021 and is Biological Sciences Division Dean for Oncology and Professor of Obstetrics and Gynecology at the University of Chicago.

Vanessa Sheppard, PhD serves as associate director for Community Outreach Engagement and Health Disparities at Virginia Commonwealth University (VCU) Massey Cancer Center. She is also chair of the Department of Health Behavior and Policy at VCU.

Aleksandar Zafirovski, MBA is the executive director and associate director for Administration at the Robert H. Lurie Comprehensive Cancer Center of Northwestern University.

We also wish to thank our departing members, Deborah Erwin, PhD and Theodore Yank, MHA, for their years of service. Their advice, expertise and open comments helped to strengthen our center and lead us in the right direction.

Cleveland-based GenomOncology and University Hospitals (UH) Seidman Cancer Center have entered into a market-leading partnership to increase clinical trial accrual rates. Utilizing GenomOncology's Precision Decision and GO Connect solutions, UH will be able to automate the patient analysis and treatment matching process to help scale their precision oncology program.

From The Daily: A team of researchers, led by biomedical engineering professor Anirban Sen Gupta, PhD is working toward innovating and advancing platelet-inspired nanotechnology systems to treat severe bleeding in surgery and trauma.

The National Institutes of Health (NIH) has awarded a $2.1 million, four-year research grant to Sen Gupta and collaborators at the University of Michigan and University of North Carolina, to advance the design of artificial platelets that can promote and stabilize clots to stop bleeding. Dr. Sen Gupta is a member of the Case Comprehensive Cancer Center's Cancer Imaging Program.

The Center for Immunotherapy and Precision Immuno-Oncology (CITI) at Cleveland Clinic Lerner Research Institute is currently seeking a postdoc, a computational biologist and faculty in translational cell based therapies for neurological disorders.

Available award: Up to $40,000

Available award: $75,000 for one year

Available award: Up to $120,000 for one year

Available award: $75,000 for 18 months

Available award: $180,000 for 18 months

Available award: $25,000 for one year

Available award: up to $150,000

The 2022 Harrington Scholar-Innovator Award is now open and accepting Letters of Intent. The award offers inventive physician-scientists resources and expertise to advance their discoveries into medicines. Intellectual property rights are retained by the award recipient or his or her institution. Up to 10 applicants will be selected to receive:

The call is open to physician-scientists at accredited academic medical centers, research institutions and universities in the United States and Canada. Selection criteria include innovation, creativity and potential for impact on human health. Applicants must have a doctorate in medicine. Award recipients will be selected by the Harrington Discovery Institute’s Scientific Advisory Board and announced in first quarter of 2022.

This 5th virtual meeting of the National Cancer Institute (NCI) Board of Scientific Advisors (BSA) was held last week. The next virtual meeting will be the 4th virtual joint meeting of the NCI's BSA and National Cancer Advisory Board (NCAB) June 13-15, 2021. While minutes from the meeting are forthcoming, recordings and individual presentations are linked below.

NCI Director's Report - Norman Sharpless, MD

Legislative Report - M.K. Holohan, JD

NCI Center for Global Health – Celebrating 10 years and Looking Ahead - Satish Gopal, MD, MPH

Canine Cancer Immunotherapy Network (K9CIN) (RFA) - Connie Sommers, PhD

Radiation Oncology-Biology Integration Network (ROBIN) (RFA) - Jeffrey Buchsbaum, MD, PHD &

Michael Graham Espey, PhD

Cascade: A Global Clinical Trials Network to Improve Screening and Preventive Therapy Outcomes for Cervical Cancer among Women Living with HIV (RFA/Coop. Agr.) - Vikrant Sahasrabuddhe, MBBS, MPH, DrPH

NCI Cancer Prevention-Interception Targeted Agent Discovery Program (CAP-IT) (RFA/Coop. Agr.) - Shizuko Sei, MD

Clinician Scientist Research Award (CSRA) (PAR) - James H. Doroshow, MD

Early Detection Research Network (EDRN) (Re-issue RFA/ Coop. Agr.) - Philip E. Castle, PhD, MPH

Acquired Resistance to Therapy Network (ARTNet) (Re-issue RFA/ Coop. Agr.) - S. Percy Ivy, MD

Pancreatic Ductal Adenocarcinoma (PDAC) Stromal Reprogramming Consortium (PSRC) (RFA) - Peter Ujhazy, MD, PhD

Research Projects for Molecular Imaging Inflammation in Cancer (MIIC) (PAR) - Janet Eary, MD

Brief Update from Cancer Training Branch, Center for Cancer Training - Oliver Bogler, PhD

Epstein Barr Virus (EBV) & non-Hodgkin's Lymphoma (NHL) (PAR) - Elizabeth Read-Connole, PhD

NCI Cancer Systems Biology Consortium (CSBC) (Re-issue RFA/ Coop. Agr., Limited Competition) - Shannon Hughes, PhD

SBIR Contract Topics (RFP) - Deepa Narayanan